mRNA |
Erlotinib |
gCSI |
pan-cancer |
AAC |
-0.12 |
0.06 |
mRNA |
navitoclax:sorafenib (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.071 |
0.06 |
mRNA |
pitstop2 |
CTRPv2 |
pan-cancer |
AAC |
0.091 |
0.06 |
mRNA |
selumetinib:navitoclax (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.073 |
0.06 |
mRNA |
CHM-1 |
CTRPv2 |
pan-cancer |
AAC |
0.065 |
0.06 |
mRNA |
necrosulfonamide |
CTRPv2 |
pan-cancer |
AAC |
0.076 |
0.07 |
mRNA |
COL-3 |
CTRPv2 |
pan-cancer |
AAC |
-0.073 |
0.07 |
mRNA |
vorinostat:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.07 |
0.07 |
mRNA |
Irinotecan |
gCSI |
pan-cancer |
AAC |
-0.11 |
0.07 |
mRNA |
ifosfamide |
CTRPv2 |
pan-cancer |
AAC |
-0.11 |
0.07 |